PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Indometacin 15mg/5ml oral liquid
1001010K0AAAZAZ
Indometacin (Systemic) Indometacin Musculoskeletal and Joint Diseases No data available
Indometacin 20mg/5ml oral liquid
1001010K0AAARAR
Indometacin (Systemic) Indometacin Musculoskeletal and Joint Diseases No data available
Indometacin 25mg modified-release capsules
1001010K0AAACAC
Indometacin (Systemic) Indometacin Musculoskeletal and Joint Diseases No data available
Indometacin 25mg modified-release tablets
1001010K0AAALAL
Indometacin (Systemic) Indometacin Musculoskeletal and Joint Diseases No data available
Indometacin 25mg/5ml oral suspension sugar free
1001010K0AAAEAE
Indometacin (Systemic) Indometacin Musculoskeletal and Joint Diseases No data available
Indometacin 31.25mg/5ml oral liquid
1001010K0AAAWAW
Indometacin (Systemic) Indometacin Musculoskeletal and Joint Diseases No data available
Indometacin 3mg/5ml oral liquid
1001010K0AAASAS
Indometacin (Systemic) Indometacin Musculoskeletal and Joint Diseases No data available
Indometacin 500micrograms/5ml oral liquid
1001010K0AAAUAU
Indometacin (Systemic) Indometacin Musculoskeletal and Joint Diseases No data available
Indometacin 50mg modified-release tablets
1001010K0AAAKAK
Indometacin (Systemic) Indometacin Musculoskeletal and Joint Diseases No data available
Indometacin 50mg/5ml oral liquid
1001010K0AAAVAV
Indometacin (Systemic) Indometacin Musculoskeletal and Joint Diseases No data available
Indomod 25mg modified-release capsules
1001010K0BIAAAC
Indomod Indometacin Musculoskeletal and Joint Diseases No data available
Indomod 75mg modified-release capsules
1001010K0BIABAD
Indomod Indometacin Musculoskeletal and Joint Diseases No data available
Inflectra 100mg pdr for concentrate for inf vials
1001030T0BDAAAA
Inflectra Infliximab Musculoskeletal and Joint Diseases No data available
Infliximab 100mg powder for solution for infusion vials
1001030T0AAAAAA
Infliximab Infliximab Musculoskeletal and Joint Diseases No data available
Infliximab 120mg/1ml inj pre-filled disposable devices
1001030T0AAABAB
Infliximab Infliximab Musculoskeletal and Joint Diseases No data available
Infliximab 120mg/1ml inj pre-filled syringes
1001030T0AAACAC
Infliximab Infliximab Musculoskeletal and Joint Diseases No data available
Intralgin gel
100302000BBBBAA
Proprietary compound preparation BNF 1003020 Other rubefacient and topical antirheumatic preparations Musculoskeletal and Joint Diseases No data available
Joint-Flex Daily 750mg tablets
1001050A0BCAAAB
Joint-Flex Daily (Glucosamine hydrochloride) Glucosamine hydrochloride (Rheumatic) Musculoskeletal and Joint Diseases No data available
Jomethid XL 200mg capsules
1001010L0BMAAAJ
Jomethid Ketoprofen Musculoskeletal and Joint Diseases No data available
Junior Ibuprofen 100mg/5ml oral suspension
1001010J0CDABBH
Numark Ibuprofen (Systemic) Ibuprofen Musculoskeletal and Joint Diseases No data available
Jylamvo 2mg/ml oral solution
1001030U0BHAACF
Jylamvo Methotrexate Musculoskeletal and Joint Diseases No data available
Jyseleca 100mg tablets
1001030AGBBAAAA
Jyseleca Filgotinib Musculoskeletal and Joint Diseases No data available
Jyseleca 200mg tablets
1001030AGBBABAB
Jyseleca Filgotinib Musculoskeletal and Joint Diseases No data available
Kaolin poultice 100g pouches
1003020L0AAACAC
Kaolin heavy Kaolin heavy Musculoskeletal and Joint Diseases No data available
Ketocid 200 modified-release capsules
1001010L0BIAAAJ
Ketocid 200 Ketoprofen Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.